Clinical Trials Logo
  1. Home
  2. Leukopenia
  3. NCT04283695

To Investigate the Absorption, Metabolism, Excretion, Absolute Bioavailability, and Immunogenicity of GX-I7 in Healthy Volunteers

Leukopenia Clinical Trial

Official title:
A Phase 1, Open-labeled, Single-dose, One-sequence, One-period, 3-part Study to Investigate the Absorption, Metabolism, Excretion, Absolute Bioavailability, and Immunogenicity of GX-I7 in Healthy Volunteers

Clinical Trial Summary

A Phase 1, open-labeled, single-dose, one-sequence, one-period, 3-part study to investigate the absorption, metabolism, excretion, absolute bioavailability, and immunogenicity of GX-I7 in healthy volunteers

Clinical Trial Description

A Phase 1, open-labeled, single-dose, one-sequence, one-period, 3-part study to investigate the absorption, metabolism, excretion, absolute bioavailability, and immunogenicity of GX-I7 in healthy volunteers To show ABA and Mass balance of GX-I7 ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04283695
Study type Interventional
Source Seoul National University Hospital
Contact
Status Active, not recruiting
Phase Early Phase 1
Start date July 3, 2019
Completion date May 1, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT00811928 - Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED) Phase 3
Not yet recruiting NCT06360952 - A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC
Completed NCT01407484 - Male Infertility Related With Post Infection Inflammatory Syndrome N/A
Completed NCT00059423 - Natural History Study for BEN
Recruiting NCT00967785 - A Phase I Study of Mozobil in the Treatment of Patients With WHIMS Phase 1/Phase 2
Recruiting NCT05225493 - HIV Indicator Diseases in Hospital and Primary Care